Chronic obstructive pulmonary disease and exacerbations: Clinician insights from the global Hidden Depths of COPD survey

Current Medical Research and Opinion

Volumn 30, Issue 4, 2014, Pages 667-684

  Barnes, N ^a,b   Calverley, P M A ^c   Kaplan, A ^d   Rabe, K F ^e,f  

^a GLAXOSMITHKLINE   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF KIEL   (Germany)

^f LungenClinic Grosshansdorf   (Germany)

Author keywords

Clinician reported; COPD; Exacerbation; Survey

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; STEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; HUMAN; OXYGEN THERAPY; PATIENT ASSESSMENT; PATIENT CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; COMORBIDITY; GENERAL PRACTITIONER; PRACTICE GUIDELINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

COMORBIDITY; GENERAL PRACTITIONERS; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84896458988     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.867842     Document Type: Review

References (30)

1. Soler-Cataluna JJ, Martinez-Garcia MÁ, Roman Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31
2. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38
3. National Clinical Guideline Centre - Acute and Chronic Conditions RCoP. NICE Chronic obstructive pulmonary disease (update): full guideline. 2010
4. American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD. Version 1.2. 2004
5. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15(SupplA):1-8A
6. McKenzie DK, Frith PA, Burdon JGW, et al. The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003. Med J Aust 2003;178:S1-40
7. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Revised 2011. Available at: http://www.goldcopd.org/guidelinesglobal- strategy-for-diagnosis-management.html [last accessed Nov 2013]
8. Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005;118:1415-24
9. Decramer M, Bartsch P, Pauwels R, et al. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaildi Arch Chest Dis 2003;59:62-80
10. Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly 2012;142:w13567 (1-7)
11. Glaab T, Banik N, Rutschmann OT, et al. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 2006;3:141-8
12. Glaab T, Vogelmeier C, Hellmann A, et al. Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J COPD 2012;7:101-8
13. Almagro P, Lopez Garcia F, Montero L, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010;104:253-9
14. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122
15. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65:956-62
16. van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J 2010;19:326-34
17. Rutschmann OT, Janssens JP, Vermeulen B, et al. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004;98:932-7
18. Steurer-Stey C, Dallalana K, Jungi M, et al. Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement. Qual Prim Care 2012;20:365-73
19. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006;130:1844-50
20. Barnes N, Calverley PM, Kaplan A, et al. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med 2013;13:54
21. Miravitlles M, Anzueto A, Legnani D, et al. Patient's perception of exacerbations of COPD - the PERCEIVE study. Respir Med 2007;101:453-60
22. Andersson F, Borg S, Jansson S-A, et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002; 96:700-8
23. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59:387-95
24. Halpin D. Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD 2008;5:187-200
25. Connors AFJ, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154:959-67
26. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-13
27. Perera WR, Hurst JR, Wilkinson TM, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007;29:527-34
28. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008;32:796-803
29. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46
30. Pinnock H, Kendall M, Murray SA, et al. Living and dying with severe COPD: multi-perspective longitudinal qualitative study. BMJ 2011;342:d142